Global E-Prescribing Market

E-Prescribing Comprehensive Study by Type (Stand-Alone Systems, Integrated Systems), Application (Hospital, Office-based physician), Delivery Mode (Web-based, On-premise/licensed, Cloud-based), Component (Software, Hardware, Services) Players and Region - Global Market Outlook to 2029

E-Prescribing Market by XX Submarkets | Forecast Years 2024-2029 | CAGR: 21.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About E-Prescribing
Electronic prescribing (e-prescribing) solutions are widely used in the healthcare industry for their benefits such as improved patient safety, fewer medication errors due to handwritten prescriptions, fewer medication errors due to misunderstood phone prescriptions, and lower risk of losing or losing misplaced written prescriptions. This, in turn, should spur growth in the global electronic prescription market over the forecast period. The e-prescription market is expected to continue this trend over the coming years. This is due to the increasing adoption of electronic prescription and drug delivery systems, which offer benefits such as accurate communication between health professionals and a reduction in unwanted medication errors, drug events, and healthcare costs. The increasing adoption of EHR solutions, government initiatives and incentive programs, the increasing focus on reducing the abuse of controlled substances, the increasing focus on reducing medical errors, and the need to reduce rising healthcare costs are driving the growth of the e-prescription market ahead. In addition, the outbreak of the COVID-19 pandemic has accelerated the use of telemedicine modules and telemedicine consultations. This continues to drive the adoption of e-prescribing solutions. The increasing government support for the introduction of EHR solutions and the need to reduce rising healthcare costs are the main drivers of the demand for such solutions. Despite its advantages, end-users continue to be reluctant to adopt electronic prescribing solutions, largely due to their high cost. The costs are not limited to the one-time purchase of a system, but also include recurring costs, e.g. for implementation services, maintenance, and support services, the integration of electronic prescribing in EHR / EMR, and in some training for cases, and education.

AttributesDetails
Study Period2019-2029
Base Year2023
UnitValue (USD Million)
CAGR21.1%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global E-Prescribing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Cerner Corporation (United States), Athenahealth, Inc. (United States), Allscripts (United States), eClinicalWorks (United States), DrFirst (United States), Practice Fusion, Inc. (United States), Emdeon (United States), Surescripts (United States), Henry Schein, Inc. (United States) and HealthFusion, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are CompuGroup Medical (Germany), HealthTeach (Germany), Visavi (Sweden), HealtheTech (Australia) and S4net (Argentina).

Segmentation Overview
AMA Research has segmented the market of Global E-Prescribing market by Type (Stand-Alone Systems and Integrated Systems), Application (Hospital and Office-based physician) and Region. On the basis of Type, Integrated system are dominating the market in the year 2023 where as Stand-alone system stood as second largest market share.

On the basis of application, Hospital segment is dominating the market in the year 2023 where as Office-based physician segment stood as second largest market .

On the basis of geography, the market of E-Prescribing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Delivery Mode , the sub-segment i.e. Web-based will boost the E-Prescribing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Component, the sub-segment i.e. Software will boost the E-Prescribing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
E-Prescribing is gaining importance in medical record systems and Rising demand for cloud-based solutions

Market Growth Drivers:
Government Initiatives and Incentive Programs have led to the demand of E-prescribing system, More focus on minimizing the medication errors and Advanced features of E-prescribing system drive the market growth

Challenges:
Lack of technological awareness among end users

Restraints:
Lack of patient privacy and security in E-prescribing system hamper the market growth and High cost of E-prescribing system

Opportunities:
Emerging economies in Asia Pacific region such as India, China and Japan

Market Leaders and their expansionary development strategies
In November 2023, Surescripts, a leading E-Prescribing platform in the US, announced the acquisition of eRx Network, another major player in the market. This merger consolidates their market share and strengthens their position in providing E-Prescribing solutions to healthcare providers across the country.
In December 2023, Epic Systems, a leading EHR vendor, launched its new "Care Everywhere" initiative, which includes an enhanced E-Prescribing module with real-time medication history and formulary information, aiming to reduce medication errors and improve patient safety.
The rule revises DEA regulations so as to allow practitioners to write prescriptions for controlled substances electronically. The regulations also allow pharmacies to receive, dispense and archive these electronic prescriptions. These regulations are in addition to, not a substitute for. Many states have already implemented EPCS mandates, some have laws from 2020 and many more have laws on the books. While drugs are regularly prescribed in or near any of the six states that require EPCS certification as of January 1, 2020, it should be ensured that corrections are in place to meet the mandate and that controlled substances are in place after January 1st can be prescribed.

Key Target Audience
Providers of e-prescribing systems and solutions, E-prescribing services providers, Hospitals & clinics, Healthcare insurance providers, Pharmaceuticals and E-prescribing vendors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Stand-Alone Systems
  • Integrated Systems
By Application
  • Hospital
  • Office-based physician
By Delivery Mode
  • Web-based
  • On-premise/licensed
  • Cloud-based

By Component
  • Software
  • Hardware
  • Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Government Initiatives and Incentive Programs have led to the demand of E-prescribing system
      • 3.2.2. More focus on minimizing the medication errors
      • 3.2.3. Advanced features of E-prescribing system drive the market growth
    • 3.3. Market Challenges
      • 3.3.1. Lack of technological awareness among end users
    • 3.4. Market Trends
      • 3.4.1. E-Prescribing is gaining importance in medical record systems
      • 3.4.2. Rising demand for cloud-based solutions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global E-Prescribing, by Type, Application, Delivery Mode , Component and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global E-Prescribing (Value)
      • 5.2.1. Global E-Prescribing by: Type (Value)
        • 5.2.1.1. Stand-Alone Systems
        • 5.2.1.2. Integrated Systems
      • 5.2.2. Global E-Prescribing by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Office-based physician
      • 5.2.3. Global E-Prescribing by: Component (Value)
        • 5.2.3.1. Software
        • 5.2.3.2. Hardware
        • 5.2.3.3. Services
      • 5.2.4. Global E-Prescribing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global E-Prescribing (Price)
      • 5.3.1. Global E-Prescribing by: Type (Price)
  • 6. E-Prescribing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cerner Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Athenahealth, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Allscripts (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. EClinicalWorks (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DrFirst (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Practice Fusion, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Emdeon (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Surescripts (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Henry Schein, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. HealthFusion, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global E-Prescribing Sale, by Type, Application, Delivery Mode , Component and Region (value and price ) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global E-Prescribing (Value)
      • 7.2.1. Global E-Prescribing by: Type (Value)
        • 7.2.1.1. Stand-Alone Systems
        • 7.2.1.2. Integrated Systems
      • 7.2.2. Global E-Prescribing by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Office-based physician
      • 7.2.3. Global E-Prescribing by: Component (Value)
        • 7.2.3.1. Software
        • 7.2.3.2. Hardware
        • 7.2.3.3. Services
      • 7.2.4. Global E-Prescribing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global E-Prescribing (Price)
      • 7.3.1. Global E-Prescribing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. E-Prescribing: by Type(USD Million)
  • Table 2. E-Prescribing Stand-Alone Systems , by Region USD Million (2018-2023)
  • Table 3. E-Prescribing Integrated Systems , by Region USD Million (2018-2023)
  • Table 4. E-Prescribing: by Application(USD Million)
  • Table 5. E-Prescribing Hospital , by Region USD Million (2018-2023)
  • Table 6. E-Prescribing Office-based physician , by Region USD Million (2018-2023)
  • Table 7. E-Prescribing: by Component(USD Million)
  • Table 8. E-Prescribing Software , by Region USD Million (2018-2023)
  • Table 9. E-Prescribing Hardware , by Region USD Million (2018-2023)
  • Table 10. E-Prescribing Services , by Region USD Million (2018-2023)
  • Table 11. South America E-Prescribing, by Country USD Million (2018-2023)
  • Table 12. South America E-Prescribing, by Type USD Million (2018-2023)
  • Table 13. South America E-Prescribing, by Application USD Million (2018-2023)
  • Table 14. South America E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 15. South America E-Prescribing, by Component USD Million (2018-2023)
  • Table 16. Brazil E-Prescribing, by Type USD Million (2018-2023)
  • Table 17. Brazil E-Prescribing, by Application USD Million (2018-2023)
  • Table 18. Brazil E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 19. Brazil E-Prescribing, by Component USD Million (2018-2023)
  • Table 20. Argentina E-Prescribing, by Type USD Million (2018-2023)
  • Table 21. Argentina E-Prescribing, by Application USD Million (2018-2023)
  • Table 22. Argentina E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 23. Argentina E-Prescribing, by Component USD Million (2018-2023)
  • Table 24. Rest of South America E-Prescribing, by Type USD Million (2018-2023)
  • Table 25. Rest of South America E-Prescribing, by Application USD Million (2018-2023)
  • Table 26. Rest of South America E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 27. Rest of South America E-Prescribing, by Component USD Million (2018-2023)
  • Table 28. Asia Pacific E-Prescribing, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific E-Prescribing, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific E-Prescribing, by Application USD Million (2018-2023)
  • Table 31. Asia Pacific E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 32. Asia Pacific E-Prescribing, by Component USD Million (2018-2023)
  • Table 33. China E-Prescribing, by Type USD Million (2018-2023)
  • Table 34. China E-Prescribing, by Application USD Million (2018-2023)
  • Table 35. China E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 36. China E-Prescribing, by Component USD Million (2018-2023)
  • Table 37. Japan E-Prescribing, by Type USD Million (2018-2023)
  • Table 38. Japan E-Prescribing, by Application USD Million (2018-2023)
  • Table 39. Japan E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 40. Japan E-Prescribing, by Component USD Million (2018-2023)
  • Table 41. India E-Prescribing, by Type USD Million (2018-2023)
  • Table 42. India E-Prescribing, by Application USD Million (2018-2023)
  • Table 43. India E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 44. India E-Prescribing, by Component USD Million (2018-2023)
  • Table 45. South Korea E-Prescribing, by Type USD Million (2018-2023)
  • Table 46. South Korea E-Prescribing, by Application USD Million (2018-2023)
  • Table 47. South Korea E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 48. South Korea E-Prescribing, by Component USD Million (2018-2023)
  • Table 49. Taiwan E-Prescribing, by Type USD Million (2018-2023)
  • Table 50. Taiwan E-Prescribing, by Application USD Million (2018-2023)
  • Table 51. Taiwan E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 52. Taiwan E-Prescribing, by Component USD Million (2018-2023)
  • Table 53. Australia E-Prescribing, by Type USD Million (2018-2023)
  • Table 54. Australia E-Prescribing, by Application USD Million (2018-2023)
  • Table 55. Australia E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 56. Australia E-Prescribing, by Component USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific E-Prescribing, by Type USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific E-Prescribing, by Application USD Million (2018-2023)
  • Table 59. Rest of Asia-Pacific E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 60. Rest of Asia-Pacific E-Prescribing, by Component USD Million (2018-2023)
  • Table 61. Europe E-Prescribing, by Country USD Million (2018-2023)
  • Table 62. Europe E-Prescribing, by Type USD Million (2018-2023)
  • Table 63. Europe E-Prescribing, by Application USD Million (2018-2023)
  • Table 64. Europe E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 65. Europe E-Prescribing, by Component USD Million (2018-2023)
  • Table 66. Germany E-Prescribing, by Type USD Million (2018-2023)
  • Table 67. Germany E-Prescribing, by Application USD Million (2018-2023)
  • Table 68. Germany E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 69. Germany E-Prescribing, by Component USD Million (2018-2023)
  • Table 70. France E-Prescribing, by Type USD Million (2018-2023)
  • Table 71. France E-Prescribing, by Application USD Million (2018-2023)
  • Table 72. France E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 73. France E-Prescribing, by Component USD Million (2018-2023)
  • Table 74. Italy E-Prescribing, by Type USD Million (2018-2023)
  • Table 75. Italy E-Prescribing, by Application USD Million (2018-2023)
  • Table 76. Italy E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 77. Italy E-Prescribing, by Component USD Million (2018-2023)
  • Table 78. United Kingdom E-Prescribing, by Type USD Million (2018-2023)
  • Table 79. United Kingdom E-Prescribing, by Application USD Million (2018-2023)
  • Table 80. United Kingdom E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 81. United Kingdom E-Prescribing, by Component USD Million (2018-2023)
  • Table 82. Netherlands E-Prescribing, by Type USD Million (2018-2023)
  • Table 83. Netherlands E-Prescribing, by Application USD Million (2018-2023)
  • Table 84. Netherlands E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 85. Netherlands E-Prescribing, by Component USD Million (2018-2023)
  • Table 86. Rest of Europe E-Prescribing, by Type USD Million (2018-2023)
  • Table 87. Rest of Europe E-Prescribing, by Application USD Million (2018-2023)
  • Table 88. Rest of Europe E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 89. Rest of Europe E-Prescribing, by Component USD Million (2018-2023)
  • Table 90. MEA E-Prescribing, by Country USD Million (2018-2023)
  • Table 91. MEA E-Prescribing, by Type USD Million (2018-2023)
  • Table 92. MEA E-Prescribing, by Application USD Million (2018-2023)
  • Table 93. MEA E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 94. MEA E-Prescribing, by Component USD Million (2018-2023)
  • Table 95. Middle East E-Prescribing, by Type USD Million (2018-2023)
  • Table 96. Middle East E-Prescribing, by Application USD Million (2018-2023)
  • Table 97. Middle East E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 98. Middle East E-Prescribing, by Component USD Million (2018-2023)
  • Table 99. Africa E-Prescribing, by Type USD Million (2018-2023)
  • Table 100. Africa E-Prescribing, by Application USD Million (2018-2023)
  • Table 101. Africa E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 102. Africa E-Prescribing, by Component USD Million (2018-2023)
  • Table 103. North America E-Prescribing, by Country USD Million (2018-2023)
  • Table 104. North America E-Prescribing, by Type USD Million (2018-2023)
  • Table 105. North America E-Prescribing, by Application USD Million (2018-2023)
  • Table 106. North America E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 107. North America E-Prescribing, by Component USD Million (2018-2023)
  • Table 108. United States E-Prescribing, by Type USD Million (2018-2023)
  • Table 109. United States E-Prescribing, by Application USD Million (2018-2023)
  • Table 110. United States E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 111. United States E-Prescribing, by Component USD Million (2018-2023)
  • Table 112. Canada E-Prescribing, by Type USD Million (2018-2023)
  • Table 113. Canada E-Prescribing, by Application USD Million (2018-2023)
  • Table 114. Canada E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 115. Canada E-Prescribing, by Component USD Million (2018-2023)
  • Table 116. Mexico E-Prescribing, by Type USD Million (2018-2023)
  • Table 117. Mexico E-Prescribing, by Application USD Million (2018-2023)
  • Table 118. Mexico E-Prescribing, by Delivery Mode USD Million (2018-2023)
  • Table 119. Mexico E-Prescribing, by Component USD Million (2018-2023)
  • Table 120. E-Prescribing: by Type(USD/Units)
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. E-Prescribing: by Type(USD Million)
  • Table 132. E-Prescribing Stand-Alone Systems , by Region USD Million (2024-2029)
  • Table 133. E-Prescribing Integrated Systems , by Region USD Million (2024-2029)
  • Table 134. E-Prescribing: by Application(USD Million)
  • Table 135. E-Prescribing Hospital , by Region USD Million (2024-2029)
  • Table 136. E-Prescribing Office-based physician , by Region USD Million (2024-2029)
  • Table 137. E-Prescribing: by Component(USD Million)
  • Table 138. E-Prescribing Software , by Region USD Million (2024-2029)
  • Table 139. E-Prescribing Hardware , by Region USD Million (2024-2029)
  • Table 140. E-Prescribing Services , by Region USD Million (2024-2029)
  • Table 141. South America E-Prescribing, by Country USD Million (2024-2029)
  • Table 142. South America E-Prescribing, by Type USD Million (2024-2029)
  • Table 143. South America E-Prescribing, by Application USD Million (2024-2029)
  • Table 144. South America E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 145. South America E-Prescribing, by Component USD Million (2024-2029)
  • Table 146. Brazil E-Prescribing, by Type USD Million (2024-2029)
  • Table 147. Brazil E-Prescribing, by Application USD Million (2024-2029)
  • Table 148. Brazil E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 149. Brazil E-Prescribing, by Component USD Million (2024-2029)
  • Table 150. Argentina E-Prescribing, by Type USD Million (2024-2029)
  • Table 151. Argentina E-Prescribing, by Application USD Million (2024-2029)
  • Table 152. Argentina E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 153. Argentina E-Prescribing, by Component USD Million (2024-2029)
  • Table 154. Rest of South America E-Prescribing, by Type USD Million (2024-2029)
  • Table 155. Rest of South America E-Prescribing, by Application USD Million (2024-2029)
  • Table 156. Rest of South America E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 157. Rest of South America E-Prescribing, by Component USD Million (2024-2029)
  • Table 158. Asia Pacific E-Prescribing, by Country USD Million (2024-2029)
  • Table 159. Asia Pacific E-Prescribing, by Type USD Million (2024-2029)
  • Table 160. Asia Pacific E-Prescribing, by Application USD Million (2024-2029)
  • Table 161. Asia Pacific E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 162. Asia Pacific E-Prescribing, by Component USD Million (2024-2029)
  • Table 163. China E-Prescribing, by Type USD Million (2024-2029)
  • Table 164. China E-Prescribing, by Application USD Million (2024-2029)
  • Table 165. China E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 166. China E-Prescribing, by Component USD Million (2024-2029)
  • Table 167. Japan E-Prescribing, by Type USD Million (2024-2029)
  • Table 168. Japan E-Prescribing, by Application USD Million (2024-2029)
  • Table 169. Japan E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 170. Japan E-Prescribing, by Component USD Million (2024-2029)
  • Table 171. India E-Prescribing, by Type USD Million (2024-2029)
  • Table 172. India E-Prescribing, by Application USD Million (2024-2029)
  • Table 173. India E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 174. India E-Prescribing, by Component USD Million (2024-2029)
  • Table 175. South Korea E-Prescribing, by Type USD Million (2024-2029)
  • Table 176. South Korea E-Prescribing, by Application USD Million (2024-2029)
  • Table 177. South Korea E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 178. South Korea E-Prescribing, by Component USD Million (2024-2029)
  • Table 179. Taiwan E-Prescribing, by Type USD Million (2024-2029)
  • Table 180. Taiwan E-Prescribing, by Application USD Million (2024-2029)
  • Table 181. Taiwan E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 182. Taiwan E-Prescribing, by Component USD Million (2024-2029)
  • Table 183. Australia E-Prescribing, by Type USD Million (2024-2029)
  • Table 184. Australia E-Prescribing, by Application USD Million (2024-2029)
  • Table 185. Australia E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 186. Australia E-Prescribing, by Component USD Million (2024-2029)
  • Table 187. Rest of Asia-Pacific E-Prescribing, by Type USD Million (2024-2029)
  • Table 188. Rest of Asia-Pacific E-Prescribing, by Application USD Million (2024-2029)
  • Table 189. Rest of Asia-Pacific E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 190. Rest of Asia-Pacific E-Prescribing, by Component USD Million (2024-2029)
  • Table 191. Europe E-Prescribing, by Country USD Million (2024-2029)
  • Table 192. Europe E-Prescribing, by Type USD Million (2024-2029)
  • Table 193. Europe E-Prescribing, by Application USD Million (2024-2029)
  • Table 194. Europe E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 195. Europe E-Prescribing, by Component USD Million (2024-2029)
  • Table 196. Germany E-Prescribing, by Type USD Million (2024-2029)
  • Table 197. Germany E-Prescribing, by Application USD Million (2024-2029)
  • Table 198. Germany E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 199. Germany E-Prescribing, by Component USD Million (2024-2029)
  • Table 200. France E-Prescribing, by Type USD Million (2024-2029)
  • Table 201. France E-Prescribing, by Application USD Million (2024-2029)
  • Table 202. France E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 203. France E-Prescribing, by Component USD Million (2024-2029)
  • Table 204. Italy E-Prescribing, by Type USD Million (2024-2029)
  • Table 205. Italy E-Prescribing, by Application USD Million (2024-2029)
  • Table 206. Italy E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 207. Italy E-Prescribing, by Component USD Million (2024-2029)
  • Table 208. United Kingdom E-Prescribing, by Type USD Million (2024-2029)
  • Table 209. United Kingdom E-Prescribing, by Application USD Million (2024-2029)
  • Table 210. United Kingdom E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 211. United Kingdom E-Prescribing, by Component USD Million (2024-2029)
  • Table 212. Netherlands E-Prescribing, by Type USD Million (2024-2029)
  • Table 213. Netherlands E-Prescribing, by Application USD Million (2024-2029)
  • Table 214. Netherlands E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 215. Netherlands E-Prescribing, by Component USD Million (2024-2029)
  • Table 216. Rest of Europe E-Prescribing, by Type USD Million (2024-2029)
  • Table 217. Rest of Europe E-Prescribing, by Application USD Million (2024-2029)
  • Table 218. Rest of Europe E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 219. Rest of Europe E-Prescribing, by Component USD Million (2024-2029)
  • Table 220. MEA E-Prescribing, by Country USD Million (2024-2029)
  • Table 221. MEA E-Prescribing, by Type USD Million (2024-2029)
  • Table 222. MEA E-Prescribing, by Application USD Million (2024-2029)
  • Table 223. MEA E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 224. MEA E-Prescribing, by Component USD Million (2024-2029)
  • Table 225. Middle East E-Prescribing, by Type USD Million (2024-2029)
  • Table 226. Middle East E-Prescribing, by Application USD Million (2024-2029)
  • Table 227. Middle East E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 228. Middle East E-Prescribing, by Component USD Million (2024-2029)
  • Table 229. Africa E-Prescribing, by Type USD Million (2024-2029)
  • Table 230. Africa E-Prescribing, by Application USD Million (2024-2029)
  • Table 231. Africa E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 232. Africa E-Prescribing, by Component USD Million (2024-2029)
  • Table 233. North America E-Prescribing, by Country USD Million (2024-2029)
  • Table 234. North America E-Prescribing, by Type USD Million (2024-2029)
  • Table 235. North America E-Prescribing, by Application USD Million (2024-2029)
  • Table 236. North America E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 237. North America E-Prescribing, by Component USD Million (2024-2029)
  • Table 238. United States E-Prescribing, by Type USD Million (2024-2029)
  • Table 239. United States E-Prescribing, by Application USD Million (2024-2029)
  • Table 240. United States E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 241. United States E-Prescribing, by Component USD Million (2024-2029)
  • Table 242. Canada E-Prescribing, by Type USD Million (2024-2029)
  • Table 243. Canada E-Prescribing, by Application USD Million (2024-2029)
  • Table 244. Canada E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 245. Canada E-Prescribing, by Component USD Million (2024-2029)
  • Table 246. Mexico E-Prescribing, by Type USD Million (2024-2029)
  • Table 247. Mexico E-Prescribing, by Application USD Million (2024-2029)
  • Table 248. Mexico E-Prescribing, by Delivery Mode USD Million (2024-2029)
  • Table 249. Mexico E-Prescribing, by Component USD Million (2024-2029)
  • Table 250. E-Prescribing: by Type(USD/Units)
  • Table 251. Research Programs/Design for This Report
  • Table 252. Key Data Information from Secondary Sources
  • Table 253. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global E-Prescribing: by Type USD Million (2018-2023)
  • Figure 5. Global E-Prescribing: by Application USD Million (2018-2023)
  • Figure 6. Global E-Prescribing: by Component USD Million (2018-2023)
  • Figure 7. South America E-Prescribing Share (%), by Country
  • Figure 8. Asia Pacific E-Prescribing Share (%), by Country
  • Figure 9. Europe E-Prescribing Share (%), by Country
  • Figure 10. MEA E-Prescribing Share (%), by Country
  • Figure 11. North America E-Prescribing Share (%), by Country
  • Figure 12. Global E-Prescribing: by Type USD/Units (2018-2023)
  • Figure 13. Global E-Prescribing share by Players 2023 (%)
  • Figure 14. Global E-Prescribing share by Players (Top 3) 2023(%)
  • Figure 15. Global E-Prescribing share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Cerner Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Cerner Corporation (United States) Revenue: by Geography 2023
  • Figure 19. Athenahealth, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Athenahealth, Inc. (United States) Revenue: by Geography 2023
  • Figure 21. Allscripts (United States) Revenue, Net Income and Gross profit
  • Figure 22. Allscripts (United States) Revenue: by Geography 2023
  • Figure 23. EClinicalWorks (United States) Revenue, Net Income and Gross profit
  • Figure 24. EClinicalWorks (United States) Revenue: by Geography 2023
  • Figure 25. DrFirst (United States) Revenue, Net Income and Gross profit
  • Figure 26. DrFirst (United States) Revenue: by Geography 2023
  • Figure 27. Practice Fusion, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Practice Fusion, Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Emdeon (United States) Revenue, Net Income and Gross profit
  • Figure 30. Emdeon (United States) Revenue: by Geography 2023
  • Figure 31. Surescripts (United States) Revenue, Net Income and Gross profit
  • Figure 32. Surescripts (United States) Revenue: by Geography 2023
  • Figure 33. Henry Schein, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Henry Schein, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. HealthFusion, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. HealthFusion, Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Global E-Prescribing: by Type USD Million (2024-2029)
  • Figure 38. Global E-Prescribing: by Application USD Million (2024-2029)
  • Figure 39. Global E-Prescribing: by Component USD Million (2024-2029)
  • Figure 40. South America E-Prescribing Share (%), by Country
  • Figure 41. Asia Pacific E-Prescribing Share (%), by Country
  • Figure 42. Europe E-Prescribing Share (%), by Country
  • Figure 43. MEA E-Prescribing Share (%), by Country
  • Figure 44. North America E-Prescribing Share (%), by Country
  • Figure 45. Global E-Prescribing: by Type USD/Units (2024-2029)
List of companies from research coverage that are profiled in the study
  • Cerner Corporation (United States)
  • Athenahealth, Inc. (United States)
  • Allscripts (United States)
  • eClinicalWorks (United States)
  • DrFirst (United States)
  • Practice Fusion, Inc. (United States)
  • Emdeon (United States)
  • Surescripts (United States)
  • Henry Schein, Inc. (United States)
  • HealthFusion, Inc. (United States)
Additional players considered in the study are as follows:
CompuGroup Medical (Germany) , HealthTeach (Germany) , Visavi (Sweden) , HealtheTech (Australia) , S4net (Argentina)
Select User Access Type

Key Highlights of Report


Jan 2024 211 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global E-Prescribing Market Quantitative research analysis
Global E-Prescribing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Cerner Corporation (United States), Athenahealth, Inc. (United States), Allscripts (United States), eClinicalWorks (United States), DrFirst (United States), Practice Fusion, Inc. (United States), Emdeon (United States), Surescripts (United States), Henry Schein, Inc. (United States) and HealthFusion, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"E-Prescribing is gaining importance in medical record systems " is seen as one of major influencing trends for E-Prescribing Market during projected period 2023-2029.
The E-Prescribing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global E-Prescribing Market Report?

Have a Query? Click Here

Other Related Reports

Spreadsheet Software Comprehensive Study by Type (Cloud based, On premise), Application (SMEs, Large Enterprises), End User (Individual, Enterprises) Players and Region - Global Market Outlook to 202...
$ 3800
Biodegradable Tableware Comprehensive Study by Type (Plates, Bowls, Cups, Cutlery, Others), Application (Commercial Use, Household Use), Distribution Channel (E-commerce, Supermarkets/Hypermarkets, R...
$ 3800
Remittance Comprehensive Study by Type (Inward Remittance, Outward Remittance), Application (Savings, Credit, Insurance, Others), End Users (Consumer, Enterprise), Channel (Money Transfer Operators (...
$ 3800
Space Debris Monitoring and Removal Comprehensive Study by Debris Size (Small Debris (<1cm), Medium Debris (1cm - 10cm), Large Debris (>10cm)), Orbit Type (Geosynchronous Orbit (GEO), Medium Earth Or...
$ 3800
SerDes Comprehensive Study by Type (Stand-alone device, IP core integrated, Application-Specific Integrated Circuit (ASIC)), Application (Ethernet, Routers, Fiber optic communications Systems, Storag...
$ 3800
Media Gateway Comprehensive Study by Type (Analog, Digital), Technology (Wire line, Wireless, Hybrid), End User (Telecommunications, BFSI, Government, Healthcare, Manufacturing, Transportation, Other...
$ 3500